These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Multiple comparisons of treatment against control under unequal variances using parametric bootstrap. Alver S; Zhang G J Appl Stat; 2024; 51(10):1861-1877. PubMed ID: 39071248 [TBL] [Abstract][Full Text] [Related]
25. Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity. Bieler GS; Williams RL Biometrics; 1993 Sep; 49(3):793-801. PubMed ID: 8241374 [TBL] [Abstract][Full Text] [Related]
26. Estimating treatment means in a mixed-effect ANOVA model for bioequivalence studies. Hsuan FC Biometrics; 1993 Sep; 49(3):703-13. PubMed ID: 8241367 [TBL] [Abstract][Full Text] [Related]
27. Efficacy evaluation for monotherapies in two-by-two factorial trials. Hung HM; Chi GY; O'Neill RT Biometrics; 1995 Dec; 51(4):1483-93. PubMed ID: 8589235 [TBL] [Abstract][Full Text] [Related]
28. Tests of independence for bivariate survival data. Shih JH; Louis TA Biometrics; 1996 Dec; 52(4):1440-9. PubMed ID: 8962462 [TBL] [Abstract][Full Text] [Related]
29. Finding the maximum safe dose level for heteroscedastic data. Tamhane AC; Logan BR J Biopharm Stat; 2004 Nov; 14(4):843-56. PubMed ID: 15587967 [TBL] [Abstract][Full Text] [Related]
30. Comparison of meta-analysis versus analysis of variance of individual patient data. Olkin I; Sampson A Biometrics; 1998 Mar; 54(1):317-22. PubMed ID: 9544524 [TBL] [Abstract][Full Text] [Related]
31. Trimmed weighted Simes' test for two one-sided hypotheses with arbitrarily correlated test statistics. Brannath W; Bretz F; Maurer W; Sarkar S Biom J; 2009 Dec; 51(6):885-98. PubMed ID: 20014203 [TBL] [Abstract][Full Text] [Related]
32. Computer program for the parametric and nonparametric comparison of several groups to a control. Blaker WD Comput Biol Med; 1987; 17(1):37-44. PubMed ID: 3816163 [TBL] [Abstract][Full Text] [Related]
33. Prediction approaches to sequentially searching for an optimal dose. Shih WJ Biometrics; 1989 Jun; 45(2):623-8. PubMed ID: 2669990 [TBL] [Abstract][Full Text] [Related]
34. Some general estimation methods for nonlinear mixed-effects models. Davidian M; Giltinan DM J Biopharm Stat; 1993 Mar; 3(1):23-55. PubMed ID: 8485535 [TBL] [Abstract][Full Text] [Related]
35. Interim treatment selection using the normal approximation approach in clinical trials. Shun Z; Lan KK; Soo Y Stat Med; 2008 Feb; 27(4):597-618. PubMed ID: 17619239 [TBL] [Abstract][Full Text] [Related]
36. Estimation of the shelf-life of drugs with mixed effects models. Chen JJ; Hwang JS; Tsong Y J Biopharm Stat; 1995 Mar; 5(1):131-40. PubMed ID: 7613558 [TBL] [Abstract][Full Text] [Related]
37. A multivariate two-sample mean test for small sample size and missing data. Wu Y; Genton MG; Stefanski LA Biometrics; 2006 Sep; 62(3):877-85. PubMed ID: 16984331 [TBL] [Abstract][Full Text] [Related]
38. Examining outlying subjects and outlying records in bioequivalence trials. Wang W; Chow SC J Biopharm Stat; 2003 Feb; 13(1):43-56. PubMed ID: 12635902 [TBL] [Abstract][Full Text] [Related]
39. Adaptive dose-finding: Proof of concept with type I error control. Miller F Biom J; 2010 Oct; 52(5):577-89. PubMed ID: 20976691 [TBL] [Abstract][Full Text] [Related]
40. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets. Siddiqui O; Hung HM; O'Neill R J Biopharm Stat; 2009; 19(2):227-46. PubMed ID: 19212876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]